Liver Disease
Conference Coverage
Liver-related deaths decline after Medicaid expansion under ACA
Investment in Medicaid expansions paid off in fewer liver-related deaths and a decrease in racial/ethnic disparities.
Conference Coverage
Liquid biopsy captures key NASH pathology hallmarks
Scanning for key proteins in serum identified fibrosis, inflammation, hepatocyte ballooning, and steatosis with high accuracy.
From the Journals
Semaglutide shows promise in NASH phase 2 study
The drug “bodes well for further study” in a condition with no FDA approved treatments.
From the Journals
Lipid profiles distinguish obese and nonobese NAFLD patients
Distinct lipid combinations showed noninvasive predictive potential for both obese and nonobese nonalcoholic fatty liver disease patients.
Conference Coverage
Cirrhosis, Child-Pugh score predict ERCP complications
Complications from endoscopic retrograde cholangiopancreatography were significantly more common in patients with cirrhosis than in those without...
Conference Coverage
Preemptive CMV monitoring beats prophylaxis post liver transplant
From the Journals
INR fails to predict bleeding in patients with cirrhosis
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international...
Conference Coverage
Time to screen for liver disease in type 2 diabetes?
Questions remain on whether or not liver surveillance should be routine in people with type 2 diabetes.
Conference Coverage
Address root causes to manage NASH
Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.
Conference Coverage
Hepatocellular carcinoma shows risk factor shift
Demographics, obesity, and metabolic factors have emerged as main drivers of disease.